Navigation Links
Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis

DUBLIN, Aug. 26, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Intranasal Drug Delivery Market 2014-2018" report to their offering.

Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. The nose is considered to be an ideal administrative route for needle-free vaccination and systematic drug delivery.

Continuous technological advancement is being made in intranasal drug delivery product to achieve efficient treatment facility. Intranasal drug delivery system plays a major role in improving the quality of the life of patients, by providing an easy mode of drug administration for patients on long-term therapy, as well as low risk of overdose and enhanced bioavailability.

The analysts forecast the Global Intranasal Drug Delivery market to grow at a CAGR of 2.92 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Intranasal Drug Delivery market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the following intranasal drug delivery systems:

  • Nasal spray
  • Nasal drop
  • Nasal powder
  • Nasal gel
  • Nasal vaccine

The report, the Global Intranasal Drug Delivery market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Intranasal Drug Delivery market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

One of the emerging trends that the market is likely to experience is an increasing adoption of non-invasive administration products. As non-invasive nasal drug delivery increases the compliance of the patient through their convenient application, they find more preference among end-users.

According to the report, one of the major drivers in the market is the increasing aging population. With growing age, people are more susceptible to developing respiratory diseases. Hence, that is an important factor in increasing the demand for intranasal drug delivery products in the market.

Further, the report states that one of the major challenges in the market is a risk of overdosing, which causes various side-effects.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Market Segmentation by Product

08. Geographical Segmentation

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

17. Key Vendor Analysis

Companies Mentioned:

  • Becton
  • Dickinson and Company
  • GlaxoSmithKline
  • Johnson & Johnson
  • Novartis
  • Actiza Pharmaceutical
  • Aptar Group
  • Korten Pharmaceuticals
  • OptiNose
  • Patheon
  • Vee Remedies
  • Zymeth Wellness

For more information visit

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact: Laura Wood, +353-1-481-1716,

SOURCE Research and Markets
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Cytomegalovirus Retinitis Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Gilead Sciences, Hospira and Shire
2. Global Veterinary Diagnostics Market 2014-2018: Key Vendors are Abaxis, Heska, IDEXX Laboratories, Mindray Medical, VCA Antech and Zoetis
3. MNX Global Logistics renews multi-year contract with NuVasive, Inc.
4. Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
5. Depomed To Present At Morgan Stanley 2014 Global Healthcare Conference
6. Cardiomyopathy Global Clinical Trials Review, H2, 2014
7. Vascular Dementias Global Clinical Trials Review, H2, 2014
8. Vocal Cord Paralysis Global Clinical Trials Review, H2, 2014
9. Traumatic Pain Global Clinical Trials Review, H2, 2014
10. Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2014
11. Tremor Global Clinical Trials Review, H2, 2014
Post Your Comments:
(Date:10/13/2015)...  Vitamin Angels – a charity that distributes vitamins ... nutritional support - announced its work continues to support ... The UN,s newly established Global Goals - announced on ... up to the Millennium Development Goals established in 2000 ... 17 Global Goals intend to address three primary objectives: ...
(Date:10/13/2015)... -- A minimally-invasive treatment just became available to men suffering ... than 10 years of clinical trials, the Food and ... High Intensity Focused Ultrasound (HIFU), a procedure that can ... and minimizing chances for erectile and urinary dysfunction associated ... pioneering Miami urologist who spearheaded ...
(Date:10/13/2015)... 13, 2015  ContraVir Pharmaceuticals, Inc. (Nasdaq: ... company focused on the development and commercialization of ... its previously announced underwritten public offering of 5,000,000 ... purchase up to 3,000,000 shares of the Company,s ... the public of $3.00. The shares of common ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... 2015 , ... Sir Grout of Greater Boston donated an expansive, seven room ... McDonald House Charities® (RMHC®). This donation was made in an effort to give back ... its inception. , “We believe strongly in the Ronald McDonald House Charities, and they ...
(Date:10/13/2015)... Diego, CA (PRWEB) , ... October 13, 2015 ... ... launch of its newest technology platform, ENGAGE, at HIMSS’s Patient Engagement Summit ... to end. , ENGAGE delivers innovative health programs and interventions via mobile devices ...
(Date:10/13/2015)... ... 2015 , ... Element Blue ™, a leading IT ... RightSensor™ LLC, an Internet of Things (IoT) hardware supplier that delivers custom and ... for customers requiring sensor hardware for critical data environments. , RightSensor™, working with ...
(Date:10/13/2015)... ... October 13, 2015 , ... NavaFit Inc. today announced the launch of its ... with, participate in local fitness & sporting events, and stay motivated. Users ... medical costs drive us to get more serious about fitness and wellness, individuals are ...
(Date:10/13/2015)... (PRWEB) , ... October 13, ... ... Postnatal Omega-3, a first-of-its kind product that targets the unique health needs ... Omega-3” of the American Pregnancy Association ( ), utilizes Nordic Naturals’ ...
Breaking Medicine News(10 mins):